Gilead Sciences Inc (GILD)

Get an in-depth profile of Gilead Sciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

9,729.000 -31.500 (-0.32%)

09/06 Closed ARS Disclaimer

Gilead Sciences Inc Company Profile

Industry: Pharmaceuticals
Sector: Healthcare
Employees: 14400
Equity Type: DRC

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Contact Information

Address: Foster City,94404 United States
Phone: 650 574 3000
Fax: 650 522 5853
Web: https://www.gilead.com

Top Executives

Name	Age	Since	Title
Eugene R. Schiff	0	0000	Member of the Scientific Advisory Board
Jacqueline K. Barton	68	1989	Independent Director
Paul E. Klotman	0	0000	Member of the Scientific Advisory Board
John W. Mellors	83	0000	Member of the Scientific Advisory Board
Francis V. Chisari	0	0000	Member of the Scientific Advisory Board
Sandra J. Horning	72	2020	Independent Director
Mark C. Genovese	0	0000	Member of Scientific Advisory Board
Daniel P. O'Day	57	2019	Chairman & CEO
Harish M. Manwani	68	2018	Independent Director
Malcolm MacCoss	73	0000	Member of Scientific Advisory Board
Nezam H. Afdhal	64	0000	Member of Scientific Advisory Board
Robert A. Harrington	0	0000	Member of the Scientific Advisory Board
Kevin E. Lofton	66	2009	Lead Independent Director
Paul Berg	94	1998	Member of Scientific Advisory Board
Kelly A. Kramer	53	2016	Independent Director
Eric J. Topol	67	0000	Member of Scientific Advisory Board
Robert T. Schooley	0	0000	Member of the Scientific Advisory Board
Kenneth C. Anderson	70	0000	Member of the Scientific Advisory Board
Brian J. Druker	66	0000	Member of the Scientific Advisory Board
Joel R. Huff	0	0000	Chairperson of Scientific Advisory Board
Javier J. Rodriguez	50	2020	Independent Director
Jeffrey A. Bluestone	68	2020	Independent Director
Anthony Welters	66	2020	Independent Director

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.